Clinical trial
A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma
NCT00980382 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- August 31, 2007
- Enrollment
- 85 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.